Drug
Quemliclustat
Quemliclustat: highest development phase Phase 3, developed by Arcus Biosciences. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Arcus Biosciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| Quemliclustat NCT06608927 | Phase 3 | Metastatic Pancreatic Ductal Adenocarcinoma |
| Quemliclustat NCT05915442 | Phase 2 | Oligometastatic Prostate Cancer |
| Quemliclustat NCT07364214 | Phase 1 | Healthy Participants |
Latest
No recent events.
Follow Quemliclustat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.